Thermo Fisher Scientific Inc. (LON: 0R0H)
Market Cap | 159.44B |
Revenue (ttm) | 31.62B |
Net Income (ttm) | 4.58B |
Shares Out | n/a |
EPS (ttm) | 11.90 |
PE Ratio | 34.82 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | Dec 13, 2024 |
Volume | 1,429 |
Open | 517.00 |
Previous Close | 517.20 |
Day's Range | 515.25 - 525.01 |
52-Week Range | 416.66 - 603.14 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Jan 29, 2025 |
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno... [Read more]
Financial Performance
In 2023, Thermo Fisher Scientific's revenue was $42.86 billion, a decrease of -4.58% compared to the previous year's $44.92 billion. Earnings were $6.00 billion, a decrease of -13.74%.
Financial numbers in USD Financial StatementsNews
TMO has been a fabulous performer over the last decade, says Jim Cramer
'Ma Money' host Jim Cramer talks how to play Thermo Fisher.
Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific
LAKEWOOD, N.J.--(BUSINESS WIRE)--Knipper Health, Inc., the largest supplier of end-to-end pharmaceutical healthcare marketing services and solutions in the U.S. serving the biopharmaceutical and medic...
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 10 years by 3.93% on an annualized basis producing an average annual return of 15.26%. Currently, Thermo Fisher Scientif...
Thermo Fisher: The Cycle Has Already Turned Around
Thermo Fisher stock is a buy with signs of recovery and potential growth, backed by positive sales and margins. Read an analysis of TMO stock here.
Invest with Confidence: Intrinsic Value Unveiled of Thermo Fisher Scientific Inc
Invest with Confidence: Intrinsic Value Unveiled of Thermo Fisher Scientific Inc
Thermo Fisher Scientific: Renewed Growth Momentum After The Pandemic
Thermo Fisher Scientific's valuation multiples offer potential capital appreciation. Learn why TMO stock is a Buy, with growth drivers in 2025 and beyond.
Thermo Fisher: M&A And Innovation To Drive Sales Growth
Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued success with strong ROEs.
Thermo Fisher Scientific Inc (TMO) Completes $1 Billion Share Repurchase
Thermo Fisher Scientific Inc (TMO) Completes $1 Billion Share Repurchase
Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 and CTS Detachable Dynabeads CD8 (CTS Deta...
Thermo Fisher Scientific completes $1B share repurchase
Thermo Fisher Scientific completes $1B share repurchase, with $3B still available for buybacks.
Thermo Fisher Scientific Completes $1B Share Repurchase
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the repurchase of $1 billion (1.9 million shares)...
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Mainz Biomed N.V. (NASDAQ: MYNZ) announced a 1-for-40 reverse stock split , effective Dec. 3. The company specializes in the early detection of cancer. Last month, Mainz Biomed reported a collaborati...
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Mainz Biomed N.V. MYNZ announced a 1-for-40 reverse stock split, effective Dec. 3.
Qatar Precision Health Institute advances precision health through transformative workshop
The workshop was co-organized with IARC/WHO and Thermo Fisher Scientific, with 17 countries participating
Jamie Murray's Top Picks: Adyen, Thermo Fisher Scientific and Northland Power
Jamie Murray, portfolio manager at Murray Wealth Group discusses his top picks: Adyen, Thermo Fisher Scientific and Northland Power.
Thermo Fisher Scientific Inc. (TMO) Wolfe 2024 Healthcare Conference (Transcript)
Thermo Fisher Scientific Inc. (NYSE:TMO) Wolfe 2024 Healthcare Results Conference November 19, 2024 8:00 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Confe...
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion...
Thermo Fisher Scientific: Near The Bottom And Attractively Valued
Thermo Fisher Scientific has strong growth prospects due to easing COVID-19 headwinds, improving Chinese and biotech markets, and favorable funding environments. The company's margins should benefit f...
Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....
Tradepulse Power Inflow Alert: Thermo Fisher Scientific Inc. Climbs Over 9 Points On Session After Alert
Thermo Fisher Scientific, Inc. today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.
Thermo Fisher Scientific Inc. (TMO) Q3 2024 Earnings Call Transcript
Thermo Fisher Scientific Inc. (NYSE:TMO) Q3 2024 Earnings Conference Call October 23, 2024 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, P...
Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'
I am upgrading Thermo Fisher Scientific Inc. to a “Buy” with a fair value of $610 per share due to anticipated recovery in the pharma and biotech industries. Thermo Fisher's high-impact innovations an...
Thermo Fisher raises profit forecast on strong demand for its tools and services
Thermo Fisher Scientific on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this year, betting on improved demand for its tools and services used in drug d...
Thermo Fisher Scientific Reports Third Quarter 2024 Results
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 28, 2024. Th...